has approval for 89 Abbreviated New Drug Applications and is selling 255 dosing presentations. Acquisitions Teva Pharmaceuticals (UK & Ireland) In 2016, Intas acquired the assets of Teva Pharmaceuticals in the UK and Ireland for US$764 million. Actavis (UK & Ireland) In 2017, the company's Accord Healthcare announced acquisition of Actavis UK Ltd. and Actavis Ireland Ltd from Teva Pharmaceutical Industries, for an enterprise value of £603 million. The deal included a portfolio of generic medicines and a manufacturing plant in Barnstaple. Sanofi's Fawdon Plant In 2018, Intas' subsidiary Accord Healthcare reopened Sanofi 's Fawdon plant in the UK for manufacturing generic effervescent medicines. The plant was acquired in 2015 after Sanofi closed the facility. This is the fifth manufacturing location for Accord in the country after Harrow, Barnstaple, Haverhill, and Didcot. Controversies In December 2020, the company along with Mankind Pharma received show-cause notices for selling anti-diabetic medicine without seeking price approval from National Pharmaceutical Pricing Authority. References External links Official site Indian brands Pharmaceutical companies of India Biotechnology companies of India Pharmaceutical companies established in 1977 Manufacturing companies based in Ahmedabad 1977 establishments in Gujarat